Clinical Trial Update: Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel with radiotherapy, with or without cisplatin, for locally advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED